This guidance document is based on Vietnam clinic organised by the RA committee where multiple Vietnam related issues such as Decree 111, COO requirements, local label requirements and risk classification were discussed in detail.
We are currently upgrading our website. Please bear with us if you are experiencing any loading issues.
The Voice of MedTech in Asia
This guidance document is based on Vietnam clinic organised by the RA committee where multiple Vietnam related issues such as Decree 111, COO requirements, local label requirements and risk classification were discussed in detail.
APACMed provides a unifying voice for the medical devices and in-vitro diagnostics industry in Asia Pacific. Founded in 2014, APACMed strives to promote innovation and impact policy that advances healthcare access for patients.
© Asia Pacific Medical Technology Association Ltd. All rights reserved. Read Our Terms Of Use